Lyra Therapeutics lyratherapeutics.com


Public lists: Pharma Startups (4732)

Lyra Therapeutics, fka 480 Biomedical, is a clinical-stage biotechnology company developing medicines precisely designed to target ear, nose and throat (ENT) diseases, offering an alternative to conventional treatments or surgeries. The company's lead drug candidate, LYR-210, offers an approach for directing anti-inflammatory medicine deep into sinonasal tissues for up to six months of therapy. Lyra is applying its transmucosal therapeutic system – comprised of drug administered through a poly...Show all

Lyra Therapeutics, fka 480 Biomedical, is a clinical-stage biotechnology company developing medicines precisely designed to target ear, nose and throat (ENT) diseases, offering an alternative to conventional treatments or surgeries. The company's lea...Show all

Company (Alive / Active)

Phone: 617-393-4600

Fax:

480 Arsenal Street

Watertown, 02172
Massachusetts, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Lyra Therapeutics $78.1M Sep 26, 2018

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Lyra Therapeutics Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
North Bridge Venture PartnersVenture CapitalWaltham, Massachusetts, United StatesSeries B, Series A - II, Series A, Debt, Seed VC
InterSouth PartnersVenture CapitalDurham, North Carolina, United StatesSeries B, Series A - II, Series A, Debt, Seed VC
Perceptive AdvisorsHedge FundNew York, New York, United StatesSeries B
Essex WoodlandsGrowth EquityNew York, New York, United StatesSeries A, Debt
ArrowMark PartnersAsset/Investment ManagementDenver, Colorado, United StatesSeries B
See all 9 investors
There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)
Drug-eluting medical implants Mar 21, 2016 Mar 06, 2018 Patent
Stent delivery system Sep 24, 2013 Jul 18, 2017 Patent
Medical implant Feb 22, 2011 Mar 08, 2016 Patent
Drug-eluting medical implants Dec 11, 2013 Feb 23, 2016 Patent
Polymeric implant delivery system Sep 07, 2012 Dec 01, 2015 Patent
See all 14 patents